Thomas Russo
Gardner Russo & Quinn
Thomas Russo AbbVie Inc stake
total: 273
Gardner Russo & Quinn ABBV trades
- Total transactions:
- 21
- New positions:
- 1
- Added:
- 5
- Reduced:
- 15
- Held since:
- 2013 Q2 or earlier
- Held for:
- 53+ quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, Thomas Russo holds 12,410 AbbVie Inc (ABBV) shares with a market value of roughly $3.12M accounting for 0.03% of the overall portfolio. Gardner Russo & Quinn has held ABBV since at least 2013 Q2 with 87,127 shares in our earliest available record. Since at least 2013 Q2, Gardner Russo & Quinn has made 20 more transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $42.63
- Weighted AVG sell price:
- $60.67
Thomas Russo's historical trades in AbbVie Inc
21 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.02%
|
12,410
|
$177.70
|
$2,205,257
|
-0.80% (-100)
|
-0%
|
|
2023 Q4
|
0.02%
|
12,510
|
$154.97
|
$1,938,675
|
-0.58% (-73)
|
-0%
|
|
2023 Q3
|
0.02%
|
12,583
|
$149.06
|
$1,875,622
|
-0.06% (-8)
|
-0%
|
|
2023 Q2
|
0.02%
|
12,591
|
$134.73
|
$1,696,385
|
-0.15% (-19)
|
-0%
|
|
2022 Q2
|
0.02%
|
12,610
|
$153.13
|
$1,931,000
|
-2.32% (-300)
|
-0%
|
|
2021 Q3
|
0.01%
|
12,910
|
$107.90
|
$1,393,000
|
+2.38% (+300)
|
+0%
|
|
2020 Q3
|
0.01%
|
$87.63
|
+0.13% (+16)
|
|||
|
2020 Q2
|
0.01%
|
$98.14
|
+0.67% (+84)
|
|||
|
2020 Q1
|
0.01%
|
$76.18
|
-2.34% (-300)
|
|||
|
2019 Q4
|
0.01%
|
$88.52
|
-1.54% (-200)
|
|||
|
2019 Q1
|
0.01%
|
$80.55
|
-6.85% (-956)
|
|||
|
2018 Q2
|
0.01%
|
$92.65
|
+1.94% (+266)
|
|||
|
2018 Q1
|
0.01%
|
$94.67
|
-2.84% (-400)
|
|||
|
2017 Q4
|
0.01%
|
$96.74
|
-20.79% (-3,700)
|
|||
|
2017 Q3
|
0.01%
|
$88.88
|
+9.88% (+1,600)
|
|||
|
2017 Q1
|
0.01%
|
$65.19
|
-5.30% (-906)
|
|||
|
2016 Q2
|
0.01%
|
$61.91
|
-21.24% (-4,612)
|
|||
|
2016 Q1
|
0.01%
|
$57.14
|
-74.96% (-65,000)
|
|||
|
2014 Q4
|
0.05%
|
$65.44
|
-0.07% (-59)
|
|||
|
2013 Q3
|
0.04%
|
$44.74
|
-0.40% (-350)
|
|||
|
2013 Q2
|
0.04%
|
$41.34
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.